{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:07:04Z","timestamp":1790424424385,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2002,6,27]],"date-time":"2002-06-27T00:00:00Z","timestamp":1025136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,6,27]],"date-time":"2002-06-27T00:00:00Z","timestamp":1025136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1038\/sj.gt.3301702","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T19:27:26Z","timestamp":1031081246000},"page":"946-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours"],"prefix":"10.1038","volume":"9","author":[{"given":"AV","family":"Patterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KJ","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RL","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BA","family":"Telfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Airley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Honess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Van der Kogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IJ","family":"Stratford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,6,27]]},"reference":[{"key":"BF3301702_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0360-3016(88)90002-8","volume":"14","author":"RA Gatenby","year":"1988","unstructured":"Gatenby RA et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy Int J Radiat Oncol Biol Phys 1988 14: 831\u2013838","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF3301702_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0360-3016(93)90280-9","volume":"26","author":"P Okunieff","year":"1993","unstructured":"Okunieff P et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone Int J Radiat Oncol Biol Phys 1993 26: 631\u2013636","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF3301702_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF00689633","volume":"13","author":"BA Teicher","year":"1994","unstructured":"Teicher BA . Hypoxia and drug resistance Cancer Metastasis Rev 1994 13: 39\u201368","journal-title":"Cancer Metastasis Rev"},{"key":"BF3301702_CR4","first-page":"4509","volume":"56","author":"M Hockel","year":"1996","unstructured":"Hockel M et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 1996 56: 4509\u20134515","journal-title":"Cancer Res"},{"key":"BF3301702_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","volume":"38","author":"DM Brizel","year":"1997","unstructured":"Brizel DM et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 1997 38: 285\u2013289","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF3301702_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00686295","volume":"300","author":"C Grau","year":"1992","unstructured":"Grau C, Overgaard JE . Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ Cancer Chemother Pharmacol 1992 300: 277\u2013280","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF3301702_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/379088a0","volume":"379","author":"TG Graeber","year":"1996","unstructured":"Graeber TG et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 1996 379: 88\u201391","journal-title":"Nature"},{"key":"BF3301702_CR8","first-page":"519","volume":"13","author":"IJ Stratford","year":"1998","unstructured":"Stratford IJ, Workman PB . Bioreductive drugs into the next millennium Anticancer Drug Des 1998 13: 519\u2013528","journal-title":"Anticancer Drug Des"},{"key":"BF3301702_CR9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/jeb.201.8.1153","volume":"201","author":"PJ Ratcliffe","year":"1998","unstructured":"Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW . Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression J Exp Biol 1998 201: 1153\u20131162","journal-title":"J Exp Biol"},{"key":"BF3301702_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","volume":"7","author":"GL Semenza","year":"2001","unstructured":"Semenza GL . Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol Med 2001 7: 345\u2013350","journal-title":"Trends Mol Med"},{"key":"BF3301702_CR11","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1073\/pnas.90.6.2423","volume":"90","author":"PH Maxwell","year":"1993","unstructured":"Maxwell PH, Pugh CW, Ratcliffe PJ . Inducible operation of the erythropoietin 3\u2019 enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism Proc Natl Acad Sci USA 1993 90: 2423\u20132427","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301702_CR12","first-page":"5830","volume":"59","author":"H Zhong","year":"1999","unstructured":"Zhong H et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases Cancer Res 1999 59: 5830\u20135835","journal-title":"Cancer Res"},{"key":"BF3301702_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nm0597-515","volume":"3","author":"GU Dachs","year":"1997","unstructured":"Dachs GU et al. Targeting gene expression to hypoxic tumour cells Nature Med 1997 3: 515\u2013520","journal-title":"Nature Med"},{"key":"BF3301702_CR14","first-page":"2936","volume":"60","author":"N Koshikawa","year":"2000","unstructured":"Koshikawa N, Takenaga K, Tagawa M, Sakiyama S . Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumour cells Cancer Res 2000 60: 2936\u20132941","journal-title":"Cancer Res"},{"key":"BF3301702_CR15","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/0360-3016(84)90521-2","volume":"10","author":"GE Adams","year":"1984","unstructured":"Adams GE, Ahmed I, Sheldon PW, Stratford IJ . RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo Int J Radiat Oncol Biol Phys 1984 10: 1653\u20131656","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF3301702_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-2952(86)90566-6","volume":"35","author":"IJ Stratford","year":"1986","unstructured":"Stratford IJ et al. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions Biochem Pharmacol 1986 35: 105\u2013109","journal-title":"Biochem Pharmacol"},{"key":"BF3301702_CR17","first-page":"3992","volume":"53","author":"CJ Koch","year":"1993","unstructured":"Koch CJ . Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin Cancer Res 1993 53: 3992\u20133997","journal-title":"Cancer Res"},{"key":"BF3301702_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/bjc.1997.558","volume":"76","author":"AV Patterson","year":"1997","unstructured":"Patterson AV et al. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR4233) and RSU1069 Br J Cancer 1997 76: 1338\u20131347","journal-title":"Br J Cancer"},{"key":"BF3301702_CR19","first-page":"4784","volume":"61","author":"C Coralli","year":"2001","unstructured":"Coralli C et al. Limitations of the reporter green fluorescent protein under simulated tumour conditions Cancer Res 2001 61: 4784\u20134790","journal-title":"Cancer Res"},{"key":"BF3301702_CR20","doi-asserted-by":"publisher","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","volume":"270","author":"BL Ebert","year":"1995","unstructured":"Ebert BL, Firth JD, Ratcliffe PJ . Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences J Biol Chem 1995 270: 29083\u201329089","journal-title":"J Biol Chem"},{"key":"BF3301702_CR21","first-page":"5215","volume":"61","author":"MS Wiesener","year":"2001","unstructured":"Wiesener MS et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas Cancer Res 2001 61: 5215\u20135222","journal-title":"Cancer Res"},{"key":"BF3301702_CR22","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1021\/jm00171a040","volume":"33","author":"TC Jenkins","year":"1990","unstructured":"Jenkins TC et al. Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins J Med Chem 1990 33: 2603\u20132610","journal-title":"J Med Chem"},{"key":"BF3301702_CR23","first-page":"S103","volume":"3","author":"RL Cowen","year":"2001","unstructured":"Cowen RL et al. Viral mediated gene delivery of hypoxia regulated reductive enzymes to activate bioreductive drugs and thus improve the therapeutic index of these anti-tumour agents P295 Mol Ther 2001 3: S103","journal-title":"Mol Ther"},{"key":"BF3301702_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0167-8140(99)00035-3","volume":"51","author":"C Aquino-Parsons","year":"1999","unstructured":"Aquino-Parsons C, Luo C, Vikse CM, Olive PL . Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia Radiother Oncol 1999 51: 179\u2013185","journal-title":"Radiother Oncol"},{"key":"BF3301702_CR25","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1089\/104303400750038499","volume":"11","author":"NG Rainov","year":"2000","unstructured":"Rainov NG . A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme Hum Gene Ther 2000 11: 2389\u20132401","journal-title":"Hum Gene Ther"},{"key":"BF3301702_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2307\/3580034","volume":"151","author":"JA Raleigh","year":"1999","unstructured":"Raleigh JA, Chou SC, Arteel GE, Horsman MR . Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors Radiat Res 1999 151: 580\u2013589","journal-title":"Radiat Res"},{"key":"BF3301702_CR27","first-page":"928","volume":"7","author":"R Airley","year":"2001","unstructured":"Airley R et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix Clin Cancer Res 2001 7: 928\u2013934","journal-title":"Clin Cancer Res"},{"key":"BF3301702_CR28","first-page":"703","volume":"13","author":"EO Aboagye","year":"1998","unstructured":"Aboagye EO, Kelson AB, Tracy M, Workman P . Pre-clinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94\/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography Anticancer Drug Des 1998 13: 703\u2013730","journal-title":"Anticancer Drug Des"},{"key":"BF3301702_CR29","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1093\/nar\/20.11.2902","volume":"20","author":"MJ van den Hoff","year":"1992","unstructured":"van den Hoff MJ, Moorman AF, Lamers WH . Electroporation in \u2018intracellular\u2019 buffer increases cell survival Nucleic Acids Res 1992 20: 2902","journal-title":"Nucleic Acids Res"},{"key":"BF3301702_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1667\/0033-7587(2000)154[0547:OSBOTM]2.0.CO;2","volume":"154","author":"J Bussink","year":"2001","unstructured":"Bussink J et al. Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines Radiat Res 2001 154: 547\u2013555","journal-title":"Radiat Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301702.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301702","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301702.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:48:21Z","timestamp":1648608501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,27]]},"references-count":30,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["BF3301702"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301702","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,27]]},"assertion":[{"value":"26 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}